Skip to main content
SpringerLink
Log in

Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Dyslipidemia is a common metabolic complication in polycystic ovary syndrome (PCOS). The aim of this study was to determine if differences exist in dyslipidemia in women with PCOS from different ethnic and geographical backgrounds. Methods: This retrospective study evaluated the serum fasting lipid profiles of 106 women with PCOS from the United States and 108 women with PCOS fromItaly evaluated at endocrinology clinics. Results: American women had higher mean body mass index than Italian women (36.1±8.6 vs 28.1±5.8 kg/m2, p<0.01). Low HDL-cholesterol was the most prevalent lipid abnormality in both populations. U.S. women had higher mean levels of serum total cholesterol, LDL-cholesterol, and triglycerides, and lower mean serum HDL-cholesterol. Most of these differences were due to differences in weight. After controlling for differences in weight and age, fasting serum triglycerides remained higher in U.S. women compared with Italian women [131.1 mg/dl, SE=7.8, 95% confidence interval =(115.7, 146.5) vs 99.3, SE=8.4, 95% confidence interval =(82.9, 115.8)]. Conclusions: Variations in body weight alone do not fully explain differences in dyslipidemia in women of diverse ethnic and geographical backgrounds. Genetic and environmental factors, such as diet and activity level, likely contribute to these differences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999, 84: 1897–9.

    Article  PubMed  CAS  Google Scholar 

  2. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989, 38: 1165–74.

    Article  PubMed  CAS  Google Scholar 

  3. Essah PA, Wickham EP, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. Clin Obstet Gynecol 2007, 50: 205–25.

    Article  PubMed  Google Scholar 

  4. Dokras A, Bochner M, Hollinrake E, Markhan S, Vanvoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005, 106: 131–7.

    Article  PubMed  Google Scholar 

  5. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005, 90: 1929–35.

    Article  PubMed  CAS  Google Scholar 

  6. Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JM. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87: 742–6.

    Article  PubMed  CAS  Google Scholar 

  7. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 1989, 30: 459–70.

    Article  CAS  Google Scholar 

  8. Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 2003, 18: 2289–93.

    Article  PubMed  Google Scholar 

  9. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol 2006, 154: 141–5.

    Article  PubMed  CAS  Google Scholar 

  10. Graf MJ, Richards CJ, Brown V, Meissner L, Dunaif A. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women. Clin Endocrinol (Oxf) 1990, 33: 119–31.

    Article  CAS  Google Scholar 

  11. Holte J, Bergh T, Berne C, Lithell H. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf) 1994, 41: 463–71.

    Article  CAS  Google Scholar 

  12. Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985, 61: 946–51.

    Article  PubMed  CAS  Google Scholar 

  13. Talbott E, Guzick D, Clerici A, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 1995, 15: 821–6.

    Article  PubMed  CAS  Google Scholar 

  14. Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001, 111: 607–13.

    Article  PubMed  CAS  Google Scholar 

  15. Haffner SM, D’Agostino R, Goff D, et al. LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 1999, 19: 2234–40.

    Article  PubMed  CAS  Google Scholar 

  16. Gardner CD, Winkleby MA, Fortmann SP. Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988–1994). Am J Cardiol 2000, 86: 299–304.

    Article  PubMed  CAS  Google Scholar 

  17. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 2005, 48: 649–56.

    Article  PubMed  CAS  Google Scholar 

  18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18: 499–502.

    PubMed  CAS  Google Scholar 

  19. Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994, 121: 641–7.

    Article  PubMed  CAS  Google Scholar 

  20. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997, 17: 1114–20.

    Article  CAS  Google Scholar 

  21. Gaziano JM, Hennekens CH, O’Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997, 96: 2520–5.

    Article  PubMed  CAS  Google Scholar 

  22. McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005, 96: 399–404.

    Article  PubMed  CAS  Google Scholar 

  23. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005, 294: 326–33.

    Article  PubMed  CAS  Google Scholar 

  24. Ehrmann DA. Polycystic ovary syndrome. N Eng J Med 2005, 352: 1223–36.

    Article  CAS  Google Scholar 

  25. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Diabetes 1988, 37: 1595–607.

    Article  PubMed  CAS  Google Scholar 

  26. Legro RS, Urbanek M, Kunselman AR, Leiby BE, Dunaif A. Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and under-treated. Fertil Steril 2002, 78: 51–7.

    Article  PubMed  Google Scholar 

  27. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 2003, 52: 908–15.

    Article  PubMed  CAS  Google Scholar 

  28. Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 2005, 20: 2409–13.

    Article  PubMed  Google Scholar 

  29. Vrbíková J, Vondra K, Cibula D, et al. Metabolic syndrome in young Czech women with polycystic ovary syndrome. Hum Reprod 2005, 20: 3328–32.

    Article  PubMed  Google Scholar 

  30. Gordon DJ, Rifkind BM. High-density lipoprotein—the clinical implications of recent studies. N Engl J Med 1989, 321: 1311–6.

    Article  PubMed  CAS  Google Scholar 

  31. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988, 8: 737–41.

    CAS  Google Scholar 

  32. Ashen MD, Blumenthal RS. Clinical practice. Low HDL cholesterol levels. N Engl J Med 2005, 353: 1252–60.

    Article  CAS  Google Scholar 

  33. Nofer JR, van der Giet M, Tölle M, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 2004, 113: 569–81.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  34. Shah PK, Kaul S, Nilsson J, Cercek B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II. Circulation 2001, 104: 2498–502.

    Article  PubMed  CAS  Google Scholar 

  35. Nesto RW. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Am J Cardiovasc Drugs 2005, 5: 379–87.

    Article  PubMed  CAS  Google Scholar 

  36. Temelkova-Kurktschiev T, Hanefeld M. The lipid triad in type 2 diabetes — prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes. Exp Clin Endocrinol Diabetes 2004, 112: 75–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, USA

    P. A. Essah & J. E. Nestler

  2. Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA

    J. E. Nestler

  3. Department of Clinical Medicine, University of Palermo, via delle Croci 47, 90139, Palermo, Italy

    E. Carmina MD

Authors
  1. P. A. Essah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. E. Nestler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Carmina MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Carmina MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Essah, P.A., Nestler, J.E. & Carmina, E. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. J Endocrinol Invest 31, 35–41 (2008). https://doi.org/10.1007/BF03345564

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345564

En]Keywords

Search

Navigation